Stanley T. Crooke

2012

In 2012, Stanley T. Crooke earned a total compensation of $1.6M as Chairman, President, Chief Executive Officer at Ionis Pharmaceuticals, a 18% decrease compared to previous year.

Compensation breakdown

Bonus$367,585
Option Awards$344,921
Salary$735,169
Stock Awards$90,516
Other$17,815
Total$1,556,006

Crooke received $735.2K in salary, accounting for 47% of the total pay in 2012.

Crooke also received $367.6K in bonus, $344.9K in option awards, $90.5K in stock awards and $17.8K in other compensation.

Rankings

In 2012, Stanley T. Crooke's compensation ranked 4,446th out of 11,487 executives tracked by ExecPay. In other words, Crooke earned more than 61.3% of executives.

ClassificationRankingPercentile
All
4,446
out of 11,487
61st
Division
Manufacturing
1,539
out of 4,253
64th
Major group
Chemicals And Allied Products
352
out of 1,198
71st
Industry group
Drugs
218
out of 920
76th
Industry
Pharmaceutical Preparations
168
out of 700
76th
Source: SEC filing on April 26, 2013.

Crooke's colleagues

We found four more compensation records of executives who worked with Stanley T. Crooke at Ionis Pharmaceuticals in 2012.

2012

B Parshall

Ionis Pharmaceuticals

Chief Financial Officer

2012

Richard Geary

Ionis Pharmaceuticals

Senior Vice President, Development

2012

C Bennett

Ionis Pharmaceuticals

Senior Vice President, Antisense Research

2012

Brett Monia

Ionis Pharmaceuticals

Senior Vice President, Antisense Drug Discovery

News

You may also like